JoVE Logo

Sign In

3.20 : Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the reabsorption of these drugs can be hindered. When urine becomes alkaline, weak acidic drugs become predominantly ionized. Due to the decreased permeability of ionized forms through tubular cells, these drugs remain in the lumen and are ultimately expelled in the urine. This mechanism, known as 'ion trapping,' prevents reabsorption and enhances renal clearance of unwanted drugs. For example, in cases of phenobarbital overdose—a weak acid—treatment with bicarbonate is used to alkalinize the urine. This action ionizes the drug, impeding its back diffusion. Similarly, when dealing with an overdose of weakly basic drugs such as amphetamines, urine acidification is employed to ensure the ionized drug is not reabsorbed.

Tags

Renal ExcretionTubular ReabsorptionGlomerular FiltrateDistal Convoluted TubuleLipophilic DrugsPassive ReabsorptionDrug IonizationUrine PHIon TrappingRenal ClearancePhenobarbital OverdoseBicarbonate TreatmentUrine AcidificationWeak AcidsWeak Bases

From Chapter 3:

article

Now Playing

3.20 : Drug Elimination by Renal Route: Tubular Reabsorption

Pharmacokinetics

3.2K Views

article

3.1 : פרמקוקינטיקה (Pharmacokinetics): סקירה כללית

Pharmacokinetics

5.5K Views

article

3.2 : מנגנון ספיגת תרופות: הובלת קרום פסיבית

Pharmacokinetics

3.6K Views

article

3.3 : מנגנון ספיגת תרופות: הובלת קרום בתיווך נשא

Pharmacokinetics

3.5K Views

article

3.4 : ספיגת תרופות: גורמים המשפיעים על ספיגת מערכת העיכול

Pharmacokinetics

3.8K Views

article

3.5 : זמינות ביולוגית: סקירה כללית

Pharmacokinetics

2.7K Views

article

3.6 : גורמים המשפיעים על זמינות ביולוגית: ביטול מעבר ראשון

Pharmacokinetics

6.1K Views

article

3.7 : שקילות ביולוגית: סקירה כללית

Pharmacokinetics

921 Views

article

3.8 : אפקט מעבר ראשון

Pharmacokinetics

5.1K Views

article

3.9 : מהלך הזמן של השפעת התרופה

Pharmacokinetics

1.9K Views

article

3.10 : הפצת תרופות: קשירת רקמות

Pharmacokinetics

2.5K Views

article

3.11 : מחסומים פיזיולוגיים

Pharmacokinetics

3.4K Views

article

3.12 : הפצת תרופות: קשירת חלבון פלזמה

Pharmacokinetics

4.8K Views

article

3.13 : דגמי תא: דגם תא יחיד

Pharmacokinetics

2.2K Views

article

3.14 : דגמי תאים: דגם שני תאים

Pharmacokinetics

5.2K Views

See More

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved